ENMD-2076 Monotherapy Demonstrates Anti-Cancer Activity in Recurrent, Platinum-Resistant Ovarian Clear Cell Carcinoma

An Aurora A/angiogenic kinase inhibitor named “ENMD-2076″ demonstrated anti-cancer activity in recurrent, platinum-resistant epithelial ovarian cancer patients, including three patients with a difficult-to-treat subtype of the disease referred to as “clear cell carcinoma.” An Aurora A/angiogenic kinase inhibitor named “ENMD-2076” demonstrated anti-cancer activity in recurrent, platinum-resistant epithelial ovarian cancer patients, including three patients with a [...]
Source: Libby's H*O*P*E* - Category: Cancer Authors: Tags: Clinical Trial Results Novel Therapies Pipeline Drugs Targeted Therapies angiogenic kinase inhibitor Aurora A kinase inhibitor Campbell Family Institute for Cancer Research clear cell carcinoma Dana-Farber Cancer Institute ENMD-2076 En Source Type: blogs